Regulatory PathRegulatory requirements compared

Active substances

Hydrochlorothiazide + Spironolactone

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
ALDACTAZIDE25MG;25MGtablet · oralPFIZERPrescription27 Jan 1961
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralMYLANPrescription3 Aug 1979
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralSUN PHARM INDUSTRIESPrescription2 Jul 1987
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralRUBICON RESEARCHPrescription10 Sep 2026
ALDACTAZIDE50MG;50MGtablet · oralPFIZERDiscontinued27 Jan 1961
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralIVAX PHARMSDiscontinued7 May 1980
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralCHARTWELL RXDiscontinued10 Jul 1980
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralMUTUAL PHARMDiscontinued16 Apr 1981
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralWATSON LABSDiscontinued24 Nov 1981
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralVANGARDDiscontinued14 Dec 1981
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralSUPERPHARMDiscontinued26 Aug 1985
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralPUREPAC PHARMDiscontinued6 Nov 1985
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralWATSON LABSDiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralWATSON LABSDiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralLEDERLEDiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralUPSHER SMITHDiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralUSL PHARMADiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralPARKE DAVISDiscontinued
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralASCOTDiscontinued
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE25MG;25MGtablet · oralPUREPAC PHARMDiscontinued

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
TEVA-SPIRONOLACTONE/HCTZ0061323125 MG; 25 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-SPIRONOLACTONE/HCTZ0065718250 MG; 50 MGTABLET · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACSPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB$0.48325per EA23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.